Profound Medical
PROF
54 hedge funds and large institutions have $174M invested in Profound Medical in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 8 closing their positions.
59% more call options, than puts
Call options by funds: $2.84M | Put options by funds: $1.78M
11% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 18
2% more capital invested
Capital invested by funds: $170M → $174M (+$4.1M)
0.67% more ownership
Funds ownership: 42.09% → 42.76% (+0.67%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 56 → 54 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$14.5M |
| 2 |
RA
Royce & Associates
New York
|
+$3.77M |
| 3 |
ACM
Altium Capital Management
New York
|
+$3.03M |
| 4 |
BC
Blackcrane Capital
Bellevue,
Washington
|
+$2.49M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$4.8M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.95M |
| 3 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$3.32M |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
-$1.46M |
| 5 |
GS
Gagnon Securities
New York
|
-$1.04M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Osaic Holdings
Scottsdale,
Arizona
| $4K | – | – | – |
|
52
JP Morgan Chase
New York
| $4K | +$4.84K | +202 | New |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $1K | +$1.37K | +57 | New |
|
|
RCM
54
RA Capital Management
Boston,
Massachusetts
| – | -$3.95M | -192,311 | Closed |
|
|
QC
55
Quadrature Capital
London,
United Kingdom
| – | -$1.46M | -71,400 | Closed |
|
|
WMP
56
Wealth Management Partners
Tucson,
Arizona
| – | -$554K | -20,282 | Closed |
|
57
CIBC World Market
Toronto,
Ontario, Canada
| – | -$310K | -15,096 | Closed |
|
|
BCM
58
Barometer Capital Management
Toronto,
Ontario, Canada
| – | -$118K | -4,500 | Closed |
|
|
NWA
59
Navis Wealth Advisors
Rye Brook,
New York
| – | -$49K | -2,400 | Closed |
|
60
Lazard Asset Management
New York
| – | -$23K | -1,156 | Closed |
|
|
ASN
61
Advisory Services Network
Atlanta,
Georgia
| – | -$2K | -100 | Closed |
|
62
Simplex Trading
Chicago,
Illinois
| – | +$1.03K | +43 | New |
|
PROF Hedge Fund Activity: Q1 2021 in Review
54 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q1 2021, worth a combined $174M — up 2.4% from $170M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of PROF and 6 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 20 added.
The largest buyer was Deerfield Management, adding an estimated $14.5M. The largest seller was Fidelity International, cutting an estimated $4.8M.
- 54 institutional investors held Profound Medical (PROF) as of Q1 2021, down from 56 in Q4 2020.
- Funds reported $174M of Profound Medical stock for Q1 2021, up 2.4% quarter-over-quarter.
- 6 funds opened new Profound Medical positions in Q1 2021 and 8 closed out, a net change of -2 holders.
- The largest Profound Medical buyer in Q1 2021 was Deerfield Management, an estimated $14.5M added.
- The largest Profound Medical seller in Q1 2021 was Fidelity International, an estimated $4.8M sold.
Based on aggregated 13F filings for Q1 2021.